1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Test–retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals (
- Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease (
- Hippocampal [18F]flortaucipir BPND corrected for possible spill-in of the choroid plexus retains strong clinico-pathological relationships (
- Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease (
- 2019
- Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum (
- Amyloid PET and cognitive decline in cognitively normal individuals : the SCIENCe project (
- 2018
- A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus (